Some of these articles may be available freely. Access to the full-text of the other articles requires a suitable Athens password, a journal subscription or payment.
Regan, B. Varanelli, L. (2013). Adjustment, depression, and anxiety in mild cognitive impairment and early dementia: a systematic review of psychological intervention studies. International Psychogeriatrics: IPA. December 2013; 25(12): 1963-84.
Sonntag, M. König, HH. Konnopka,A. (2013). The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review. Pharmacoeconomics. December 2013; 31(12): 1131-54.
Pan, YJ. Wu, CS. Gau, SS. [et al]. Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies. Dementia and Geriatric Cognitive Disorders. October 19th 2013; 37(3-4): 125-140. [Epub ahead of print]. Full Text Link.
Tricco, AC. Soobiah, C. Berliner, S. [et al] (2013). Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ: Canadian Medical Association Journal. November 5th 2013; 185(16): 1393-401. Full Text Link.
Kongkeaw, C. Dilokthornsakul, P. Thanarangsarit, P. [et al] (2013). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology. November 16th 2013. [Epub ahead of print].
Devos, D. Moreau, C. Dujardin, K. [et al] (2013). New pharmacological options for treating advanced Parkinson’s disease. Clinical Therapeutics. October 2013; 35(10): 1640-52. Full Text Link.
Patel AA, Reardon G, Nelson WW, Philpot T, Neidecker MV. Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation. Clinical Therapeutics. November 2013; 35(11): 1794-804.
O’Brien, J. Jackson, JW. Grodstein, F. [et al] (2014). Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer’s Disease. Epidemiological Reviews. 2014; 36(1): 83-103.
Mikulca, JA. Nguyen, V. Gajdosik, DA. [et al] (2013). Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches. Journal of Clinical Pharmacy and Therapeutics. December 8th 2013. [Epub ahead of print].
Richardson, K. Schoen, M. French, B. [et al] (2013). Statins and cognitive function: a systematic review. Annals of Internal Medicine. November 19th 2013; 159(10): 688-97.
Swiger, KJ. Manalac, RJ. Blumenthal, RS. [et al] (2013). Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clinic Proceedings. Mayo Clinic. November 2013; 88(11): 1213-21.
Atti, AR. Ferrari Gozzi, B. Zuliani, G. [et al] (2014). A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia. International Psychogeriatrics: IPA. January 2014; 26(1): 19-37.
Health Quality Ontario. Vitamin B12 and cognitive function: an evidence-based analysis. Ontario Health Technology Assessment Series. November 1st 2013; 13(23): 1-45. Full Text Link.
Godefroy, O. Leclercq, C. Bugnicourt, JM.; GRECOG-VASC Study Group. [et al] (2013). Neuropsychological assessment and cerebral vascular disease: the new standards. Revue Neurologique. October 2013; 169(10): 779-85.
[A version of this collection features in Dementia and Elderly Care: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 11, June 2014].